Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery.
J Reprod Immunol
; 144: 103285, 2021 04.
Article
in English
| MEDLINE | ID: covidwho-1062496
ABSTRACT
We report herein the longest-lasting study of SARS-CoV-2 antibody profile in pregnancy, from first trimester-infection to delivery. Seventeen out of 164 pregnant women tested positive for COVID-19. Throughout pregnancy, the neutralizing antibody titer remained stable, whilst a significant decline in the non-neutralizing antibodies was observed after 16 weeks of gestation. All the newborns of women who developed IgG antibodies showed the presence of the same antibodies in arterial cord blood. Knowledge on the longevity and type of SARS-CoV-2 antibody response may help to guide vaccination strategies in pregnancy.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pregnancy Complications, Infectious
/
Immunoglobulin G
/
Antibodies, Neutralizing
/
SARS-CoV-2
/
COVID-19
/
Antibodies, Viral
Type of study:
Cohort study
/
Observational study
/
Prognostic study
/
Qualitative research
Topics:
Vaccines
Limits:
Adult
/
Female
/
Humans
/
Pregnancy
Language:
English
Journal:
J Reprod Immunol
Year:
2021
Document Type:
Article
Affiliation country:
J.jri.2021.103285
Similar
MEDLINE
...
LILACS
LIS